Results 61 to 70 of about 213,070 (226)
Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu +6 more
wiley +1 more source
Treatment of Kaposi sarcoma herpesvirus-associated multicentric Castleman disease
Synopsis Kaposi sarcoma herpes virus (KSHV)-associated multicentric Castleman disease (MCD) is a rare, polyclonal lymphoproliferative disorder characterized by flares of inflammatory symptoms, edema, cytopenias, lymphadenopathy and splenomegaly ...
K. Lurain, R. Yarchoan, T. Uldrick
semanticscholar +1 more source
ABSTRACT Background Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) remain major global public health concerns. Oral lesions are often among the earliest manifestations of HIV, placing dentists at the forefront of early detection and management.
Tuğba Aydoğdu, Berkant Sezer
wiley +1 more source
Diagnostic dilemma in Kaposi’s sarcoma
Kaposi′s sarcoma is described as cutaneous and extracutaneous neoplasm predominantly affecting older individuals. Though earlier uncommon and endemic to certain African areas, its incidence is on a rise due to infections with human immunodeficiency virus
Rao B.S Satish +4 more
doaj +1 more source
Abstract Background Data on chemotherapeutic efficacy and tolerability for Kaposi Sarcomas (KS) in people living with HIV (PWH) and HIV‐virological control are limited. We aimed to describe clinical responses and tolerability of KS therapies in PWH with HIV‐aviraemic KS in a prospective cohort.
S. Bacquart +10 more
wiley +1 more source
Nonepidemic Kaposi sarcoma: A recently proposed category
No abstract available Keywords: HHV-8, human herpesvirus-8; KS, Kaposi sarcoma; Kaposi sarcoma; MSM, men who have sex with men; epidemiology; human herpes virus-8; immunocompetent; nonepidemic.
T. Hinojosa +8 more
semanticscholar +1 more source
This study found that BLIMP‐1 is highly expressed in activated effector/memory human regulatory T cells, especially CD39+ Tregs, where it is associated with increased IL‐10 production and a conserved phenotype across blood and lung tissues during immune responses such as SARS‐CoV‐2 infection.
Chansavath Phetsouphanh +10 more
wiley +1 more source
BACKGROUND Kaposi sarcoma herpesvirus (KSHV) is the cause of Kaposi sarcoma (KS), primary effusion lymphoma (PEL), and a form of Castleman disease (KSHV-MCD).
M. Polizzotto +14 more
semanticscholar +1 more source
Laryngeal Kaposi sarcoma: case report and literature review
Laryngeal Kaposi sarcoma: case report and literature review. Problem/Objective: Kaposi sarcoma is the most frequently-occurring neoplasm in AIDS patients. Laryngeal localization is infrequent.
G. Lawson +6 more
doaj +2 more sources
O sarcoma de Kaposi é uma neoplasia angioproliferativa maligna que na maioria das vezes se restringe à pele e ao tecido subcutâneo; porém, pode aparecer de forma mais agressiva, atingindo a cavidade oral, o trato gastrointestinal e os pulmões (sarcoma de
Jorge Agle Kalil +4 more
doaj +1 more source

